Director Ryan Barbara made three open market purchases of Indivior Pharmaceuticals ($INDV) shares in the last 365 days, totaling nearly $29,000, with the most recent on March 13, 2026. This ranks 3,480th among 4,983 insiders, well below the average of $1.5 million per buyer. He also sold MiNK Therapeutics ($INKT) shares six times for about $27,500 total, latest on March 10, 2026, ranking 10,866th out of 11,678 insiders versus an average of $8.6 million per seller.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Ryan Barbara | Director | P | Common Stock | 8 | $31.09 | 5,724.0000 | 125,000,000 | 0.14% | 0.00% |
| March 10, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 500 | $15.30 | 20,406.0000 | 4,694,155 | 2.39% | 0.01% |
| March 10, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 500 | $15.57 | 20,906.0000 | 4,694,155 | 2.34% | 0.01% |
| March 10, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 300 | $15.28 | 21,406.0000 | 4,694,155 | 1.38% | 0.01% |
| March 9, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 200 | $10.17 | 21,706.0000 | 4,694,155 | 0.91% | 0.00% |
| March 9, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Ryan Barbara | Director | P | Common Stock | 31 | $32.56 | 5,716.0000 | 125,000,000 | 0.55% | 0.00% |
| Feb. 27, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 400 | $10.86 | 22,006.0000 | 4,694,155 | 1.79% | 0.01% |
| March 2, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | S | Common Stock | 100 | $10.83 | 21,906.0000 | 4,694,155 | 0.45% | 0.00% |
| Jan. 26, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Ryan Barbara | Director | A | Common Stock | 3722 | $0.00 | 5,685.0000 | 125,000,000 | 189.61% | 0.00% |
| Jan. 5, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Ryan Barbara | Director | P | Ordinary Shares | 775 | $35.39 | 1,963.0000 | 125,000,000 | 65.24% | 0.00% |
| Jan. 2, 2026 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Stock Option (Right to Buy) | 5395 | $0.00 | 5,395.0000 | 4,694,155 | 9999.99% | 0.11% |
| Dec. 19, 2025 | Azitra, Inc. | $AZTR | Ryan Barbara | Director | A | Stock Options (Right To Buy) | 3003 | $0.00 | 3,003.0000 | 10,204,938 | 9999.99% | 0.03% |
| Dec. 1, 2025 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 1601 | $11.09 | 22,406.0000 | 4,694,155 | 7.70% | 0.03% |
| Sept. 9, 2025 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Stock Option (Right to Buy) | 3225 | $0.00 | 3,225.0000 | 3,966,392 | 9999.99% | 0.08% |
| Sept. 2, 2025 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 1281 | $13.86 | 20,805.0000 | 3,966,392 | 6.56% | 0.03% |
| Aug. 26, 2025 | INVO Fertility, Inc. | $IVF | Ryan Barbara | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,157.0000 | 1,066,065 | 9999.99% | 4.22% |
| June 2, 2025 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 2476 | $7.17 | 19,524.0000 | 3,966,392 | 14.52% | 0.06% |
| March 3, 2025 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 2019 | $8.79 | 17,048.0000 | 0 | 13.43% | 0.00% |
| Dec. 1, 2024 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 24229 | $0.73 | 150,336.0000 | 0 | 19.21% | 0.00% |
| Sept. 3, 2024 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 21649 | $0.82 | 126,107.0000 | 0 | 20.73% | 0.00% |
| June 3, 2024 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 17841 | $0.99 | 104,458.0000 | 0 | 20.60% | 0.00% |
| March 1, 2024 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 18685 | $0.95 | 86,617.0000 | 0 | 27.51% | 0.00% |
| Dec. 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 17068 | $1.04 | 67,932.0000 | 0 | 33.56% | 0.00% |
| Sept. 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Not found | A | Common Stock | 12158 | $1.46 | 50,864.0000 | 0 | 31.41% | 0.00% |
| June 14, 2023 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Director | A | Stock Option (Right to Buy) | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Director | A | Common Stock | 10086 | $1.76 | 38,930.0000 | 0 | 34.97% | 0.00% |
| May 18, 2023 | INVO Fertility, Inc. | $IVF | Ryan Barbara | Director | A | Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Ryan Barbara | Director | A | Common Stock | 8493 | $2.09 | 28,844.0000 | 0 | 41.73% | 0.00% |